Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease characterized by alveolar accumulation of surfactant lipids and proteins. It is usually autoimmune and secondary to hematologic malignancy or infection. To date, only 5 case reports of PAP associated with lung cancers, including 2 cases of squamous cell carcinoma and 3 cases of adenocarcinoma, have been published. To the best of our knowledge, no case of PAP with small cell lung carcinoma has been reported thus far. We herein report the first case of PAP associated with small cell lung carcinoma.
KimKHKimJHKimYW. Use of extracorporeal membrane oxygenation (ECMO) during whole lung lavage in pulmonary alveolar proteinosis associated with lung cancer. Eur J Cardiothorac Surg. 2004;26:1050-1051.
7.
SuKCLaySLPerngRPChangSCChenYM. Lung cancer may develop subsequently or coincidently with pulmonary alveolar proteinosis. Lung Cancer. 2007;58:144-148.
8.
LiuHWangYHeWQinghuaX. Lung squamous cell carcinoma in pulmonary alveolar proteinosis. Ann Thorac Cardiovasc Surg. 2014;20:650-653.
9.
FriemannJPottFWilkKB. Pulmonary alveolar proteinosis in rats after administration of quarts: its possible role in morphogenesis of lung cancer. J Cancer Res Clin Oncol. 1994;120:348-353.
10.
AthanassiadouPPAthanassiadesPHKostopoulosCKyrkouKPetrakakouEVeroniS. Antigen expression of alveolar macrophages in smokers and patients with lung disease. Diagn Cytopathol. 1995;12:37-41.
11.
SulkowskaMSulkowskiSChyczewskiL. Ultrastructural study of endogenous lipid pneumonia and pulmonary alveolar proteinosis coexistent with lung cancer. Folia Histochem Cytobiol. 1997;35:175-183.
